Predictive value and clinical utility of centrally-assessed ER, PgR and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

PURPOSE: The SOFT and TEXT randomized phase III trials investigated adjuvant endocrine therapies for premenopausal women with hormone receptor-positive (HR+) early breast cancer. We investigated the prognostic and predictive value of centrally-assessed levels of estrogen receptor (ER), progesterone...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast Cancer Res Treat
Главные авторы: Regan, Meredith M., Pagani, Olivia, Francis, Prudence A., Fleming, Gini F., Walley, Barbara A., Kammler, Roswitha, Dell'Orto, Patrizia, Russo, Leila, Szőke, János, Doimi, Franco, Villani, Laura, Pizzolitto, Stefano, Öhlschlegel, Christian, Sessa, Fausto, Cámara, Vicente Peg, Peralto, José Luis Rodríguez, MacGrogan, Gaëtan, Colleoni, Marco, Goldhirsch, Aron, Price, Karen N., Coates, Alan S., Gelber, Richard D., Viale, Giuseppe
Формат: Artigo
Язык:Inglês
Опубликовано: 2015
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4749471/
https://ncbi.nlm.nih.gov/pubmed/26493064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3612-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы